Shalby Limited has fulfilled its quarterly regulatory obligations by submitting the mandatory compliance certificate under SEBI regulations for the quarter ended March 31, 2026. The submission demonstrates the company's commitment to maintaining transparency and adhering to securities market regulations.

Regulatory Compliance Submission

The company submitted its certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 to both major stock exchanges. The submission details are presented below:

Certificate Authentication

KFin Technologies Ltd., serving as the Registrar and Share Transfer Agent for Shalby Limited, provided the confirmation certificate. The certificate was authenticated by Sharmila Hemant Amin, Assistant Vice President at KFin Technologies Limited, and dated April 1, 2026.

The certificate confirms that all details of securities dematerialized and rematerialized during the specified quarter have been properly furnished to stock exchanges where the company's shares are listed. This includes submissions to both National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL).

Corporate Information

Shalby Limited operates from its registered office located opposite Karnavati Club, S.G. Road, Ahmedabad, Gujarat. The company maintains its corporate identification number as L85110GJ2004PLC044667 and trades on stock exchanges under the scrip codes SHALBY (NSE) and 540797 (BSE).

Regulatory Framework

The SEBI (Depositories and Participants) Regulations 2018 mandate that companies submit quarterly certificates confirming proper handling of securities dematerialization and rematerialization processes. This regulatory requirement ensures transparency in securities transactions and maintains investor confidence in the depository system.

The timely submission of this certificate reflects Shalby Limited's adherence to corporate governance standards and regulatory compliance requirements, maintaining its good standing with securities market regulators and stock exchanges.

Shalby Limited has announced a significant expansion of its healthcare services with the inauguration of an Oncology Department along with advanced Radiotherapy facilities at Krishna Shalby Hospital in Ahmedabad. The company disclosed this major development through a regulatory filing under Regulation 30 of SEBI (LODR) Regulations, 2015 on March 23, 2026.

New Oncology Services Launch

The introduction of oncology and radiotherapy services at Krishna Shalby Hospital marks a strategic enhancement in the company's healthcare offerings. The new department is designed to ensure patients have access to comprehensive cancer treatment under one roof, eliminating the need for multiple facility visits.

Comprehensive Cancer Care Team

The newly launched department is supported by an experienced team of specialized medical professionals. The hospital has assembled a multidisciplinary team to provide complete cancer care services:

• Medical oncologists for cancer treatment and chemotherapy
• Radiation oncologists for radiotherapy services
• Surgical oncologists for cancer surgery procedures

This integrated approach enables patients to receive specialized diagnosis and treatment at a single location, streamlining the cancer care process.

Advanced Technology and Patient-Centric Approach

The oncology department leverages advanced technology combined with expert medical teams to deliver effective cancer treatment. The company emphasizes its commitment to a patient-centric approach, focusing on timely diagnosis and effective treatment for patients in and around Ahmedabad.

The launch of these advanced services positions Krishna Shalby Hospital as a comprehensive cancer care provider in the region, offering patients access to modern oncology and radiotherapy facilities without the need to seek treatment at multiple locations.